• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者肿瘤内 E-钙黏蛋白表达减少的定量分析与淋巴结转移及预后的关系。

Association of quantitative analysis of intratumoral reduced E-cadherin expression with lymph node metastasis and prognosis in patients with breast cancer.

机构信息

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto-Machi, Nagasaki, 852-8501, Japan.

Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

出版信息

Sci Rep. 2023 Jun 27;13(1):10434. doi: 10.1038/s41598-023-37012-4.

DOI:10.1038/s41598-023-37012-4
PMID:37369698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10300190/
Abstract

Loss of E-cadherin expression is a poor prognostic factor in patients with breast cancer. Breast cancer cells co-cultured with adipocytes reportedly promote E-cadherin attenuation and tumor progression. The current study aimed to investigate the association of reduced E-cadherin expression with adipose tissue invasion (ATI) and prognosis in breast cancer. Surgical specimens were collected from 188 women with invasive ductal carcinoma of the breast who had undergone surgery without neoadjuvant treatment. We compared E-cadherin expression in ATI and invasive front (IF) using immunohistochemistry with ImageJ. Reduced E-cadherin expression was detected not only in the ATI area but also in the IF, and the degree of reduced E-cadherin expression was positively correlated with both areas. In patients with lymph node metastasis compared to those without, E-cadherin expression was reduced and this reduction was associated with poor recurrence-free survival. We concluded that E-cadherin expression is reduced not only at the ATI area but also at the IF of the tumor. Reduced E-cadherin expression is a clear prognostic factor for breast cancer. Hence, future research is warranted for establishing an objective and quantitative E-cadherin staining assay that will allow clinical use of E-cadherin as a prognostic factor.

摘要

E-钙黏蛋白表达缺失是乳腺癌患者预后不良的一个因素。有报道称,与脂肪细胞共培养的乳腺癌细胞可促进 E-钙黏蛋白衰减和肿瘤进展。本研究旨在探讨 E-钙黏蛋白表达缺失与乳腺癌脂肪组织浸润(ATI)和预后的关系。研究收集了 188 例接受无新辅助治疗手术的浸润性导管癌女性的手术标本。我们使用免疫组织化学和 ImageJ 比较了 ATI 和浸润前沿(IF)的 E-钙黏蛋白表达。不仅在 ATI 区域,而且在 IF 区域也检测到 E-钙黏蛋白表达缺失,E-钙黏蛋白表达缺失的程度与两个区域均呈正相关。与无淋巴结转移的患者相比,有淋巴结转移的患者 E-钙黏蛋白表达降低,这种降低与无复发生存率差相关。我们得出结论,E-钙黏蛋白不仅在 ATI 区域,而且在肿瘤 IF 中表达缺失。E-钙黏蛋白表达缺失是乳腺癌的明确预后因素。因此,有必要进行未来的研究,建立一种客观和定量的 E-钙黏蛋白染色检测方法,以便临床应用 E-钙黏蛋白作为预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54a7/10300190/5630a8637ff7/41598_2023_37012_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54a7/10300190/c1d5b1d7256e/41598_2023_37012_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54a7/10300190/69530f32a40b/41598_2023_37012_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54a7/10300190/b46771e0151d/41598_2023_37012_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54a7/10300190/5630a8637ff7/41598_2023_37012_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54a7/10300190/c1d5b1d7256e/41598_2023_37012_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54a7/10300190/69530f32a40b/41598_2023_37012_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54a7/10300190/b46771e0151d/41598_2023_37012_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54a7/10300190/5630a8637ff7/41598_2023_37012_Fig4_HTML.jpg

相似文献

1
Association of quantitative analysis of intratumoral reduced E-cadherin expression with lymph node metastasis and prognosis in patients with breast cancer.乳腺癌患者肿瘤内 E-钙黏蛋白表达减少的定量分析与淋巴结转移及预后的关系。
Sci Rep. 2023 Jun 27;13(1):10434. doi: 10.1038/s41598-023-37012-4.
2
Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.唾液酸化路易斯X、唾液酸化路易斯A、E-钙黏蛋白和组织蛋白酶D在人乳腺癌中的表达:乳腺原位癌、浸润性癌及其淋巴结转移的免疫组织化学分析
Anticancer Res. 2005 May-Jun;25(3A):1615-22.
3
Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.E-钙黏蛋白在人乳腺导管原位癌、浸润性癌、其淋巴结转移灶、远处转移灶、复发性癌及复发中的表达
Anticancer Res. 2007 Jul-Aug;27(4A):1969-74.
4
The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.E-钙黏蛋白、α-连环蛋白和β-连环蛋白表达缺失与浸润性乳腺癌的转移及不良预后相关。
Int J Oncol. 2001 Mar;18(3):513-20.
5
Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.埃兹蛋白(ezrin)和E-钙黏蛋白(E-cadherin)的联合表达与乳腺癌的淋巴结转移及不良预后相关。
Oncol Rep. 2015 Jul;34(1):165-74. doi: 10.3892/or.2015.3967. Epub 2015 May 8.
6
Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.乳腺浸润性导管癌中E-钙黏蛋白表达与常规免疫组化指标的相关性
Cancer Biomark. 2009;5(1):1-8. doi: 10.3233/CBM-2009-0551.
7
Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.淋巴结转移灶中E-钙黏蛋白表达的自动化定量分析可预测浸润性导管癌的生存率。
Clin Cancer Res. 2005 Jun 1;11(11):4083-9. doi: 10.1158/1078-0432.CCR-04-2191.
8
The role of E-Cadherin expression in primary site of breast cancer.E-钙黏蛋白在乳腺癌原发灶中的表达作用。
Arch Gynecol Obstet. 2022 Apr;305(4):913-920. doi: 10.1007/s00404-021-06198-1. Epub 2021 Sep 12.
9
The effects of E-cadherin and bcl-2 on prognosis in patients with breast cancer.E-钙黏蛋白和bcl-2对乳腺癌患者预后的影响。
Bratisl Lek Listy. 2010;111(9):493-7.
10
[Relationship between lymph node metastasis and the expressions of E-cadherin, N-cadherin, and matrix metalloproteinase in breast carcinoma].[乳腺癌中淋巴结转移与E-钙黏蛋白、N-钙黏蛋白及基质金属蛋白酶表达之间的关系]
Ai Zheng. 2002 Sep;21(9):965-9.

引用本文的文献

1
Construction of a prediction model for peripheral lymph node metastasis in patients with colorectal cancer based on enhanced CT texture features.基于增强CT纹理特征构建结直肠癌患者外周淋巴结转移预测模型
World J Surg Oncol. 2025 Jul 7;23(1):266. doi: 10.1186/s12957-025-03928-6.
2
Breaking down physical barriers: strategies to improve lymphocyte infiltration for effective neoantigen-based therapies.突破物理屏障:改善淋巴细胞浸润以实现有效的基于新抗原疗法的策略。
Front Immunol. 2025 Jun 12;16:1614228. doi: 10.3389/fimmu.2025.1614228. eCollection 2025.
3
A Novel Compound from the Phenylsulfonylpiperazine Class: Evaluation of In Vitro Activity on Luminal Breast Cancer Cells.

本文引用的文献

1
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.辅助乳腺癌临床试验中疗效终点的更新标准化定义(STEEP):STEEP 版本 2.0。
J Clin Oncol. 2021 Aug 20;39(24):2720-2731. doi: 10.1200/JCO.20.03613. Epub 2021 May 18.
2
Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review.三阴性乳腺癌伴脂肪组织侵犯的活跃行为:单中心回顾性研究。
BMC Cancer. 2021 Apr 20;21(1):434. doi: 10.1186/s12885-021-08147-2.
3
Comparative Analysis of Immunohistochemical Staining Intensity Determined by Light Microscopy, ImageJ and QuPath in Placental Hofbauer Cells.
一种新型苯磺酰基哌嗪类化合物:对腔上皮乳腺癌细胞体外活性的评估。
Molecules. 2024 Sep 20;29(18):4471. doi: 10.3390/molecules29184471.
4
Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies.乳腺癌干细胞与肿瘤异质性:特征与治疗策略
Cancers (Basel). 2024 Jul 7;16(13):2481. doi: 10.3390/cancers16132481.
5
CSCE-cadherin immunohistochemistry panel predicts poor prognosis in oral squamous cell carcinoma.钙黏蛋白免疫组织化学检测面板预测口腔鳞状细胞癌预后不良。
Sci Rep. 2024 May 8;14(1):10583. doi: 10.1038/s41598-024-55594-5.
6
Evaluating Recurrence Risk in Patients Undergoing Breast-conserving Surgery Using E-cadherin Staining as a Biomarker.使用 E-钙黏蛋白染色作为生物标志物评估接受保乳手术患者的复发风险。
In Vivo. 2024 May-Jun;38(3):1143-1151. doi: 10.21873/invivo.13549.
光镜、ImageJ和QuPath测定胎盘霍夫鲍尔细胞免疫组化染色强度的比较分析
Acta Histochem Cytochem. 2021 Feb 25;54(1):21-29. doi: 10.1267/ahc.20-00032. Epub 2021 Feb 20.
4
Cancer-associated adipocytes: emerging supporters in breast cancer.癌症相关脂肪细胞:乳腺癌的新兴支持者。
J Exp Clin Cancer Res. 2020 Aug 12;39(1):156. doi: 10.1186/s13046-020-01666-z.
5
E-cadherin deregulation in breast cancer.E-钙黏蛋白在乳腺癌中的失调。
J Cell Mol Med. 2020 Jun;24(11):5930-5936. doi: 10.1111/jcmm.15140. Epub 2020 Apr 16.
6
Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression.在乳腺癌进展过程中上皮-间充质转化相关标志物和表型的表达。
Breast Cancer Res Treat. 2020 Jun;181(2):369-381. doi: 10.1007/s10549-020-05627-0. Epub 2020 Apr 16.
7
The 2019 World Health Organization classification of tumours of the breast.《2019年世界卫生组织乳腺肿瘤分类》
Histopathology. 2020 Aug;77(2):181-185. doi: 10.1111/his.14091. Epub 2020 Jul 29.
8
Adipocytes in the Tumour Microenvironment.肿瘤微环境中的脂肪细胞
Adv Exp Med Biol. 2020;1234:1-13. doi: 10.1007/978-3-030-37184-5_1.
9
Cancer-associated adipocytes: key players in breast cancer progression.癌相关脂肪细胞:乳腺癌进展中的关键角色。
J Hematol Oncol. 2019 Sep 10;12(1):95. doi: 10.1186/s13045-019-0778-6.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.